You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
A new study appearing in PLOS Genetics uncovers differences in methylation patterns in uterine cells from endometriosis patients as compared to controls.
Atrin will use Predictive's GenDB databases and women's health biobank to study germline mutations in DNA damage and response inhibitor pathways.
The funding will be used to support clinical validation and expand market access for the firm's endometriosis diagnostic test.
Predictive Laboratories will use Thermo Fisher reproductive health products to research the genetic basis of infertility, aiming to develop better diagnostic tools.
The firm also continues to use its methylation-specific PCR technology to develop assays for partners in the oncology space.
TwoXAR's proprietary artificial intelligence technology uses a variety of biomedical data including genomic, proteomic, and clinical data for drug discovery.
A meta-analysis involving 16,595 women with leiomyoma and 523,330 without led to 16 associated loci related to both tumorigenesis and estrogen-related traits.
By using menstrual effluent samples, the decidualization assay detects genetic biomarkers that may be linked to endometriosis.
Researchers found microbial communities at sites of the female reproductive tract thought to be sterile, and linked certain microbes to disease states.
Researchers used exome and targeted sequencing to find alterations affecting KRAS and other cancer driver genes in a subset of deep infiltrating endometriosis samples.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.